In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Structure Therapeutics Inc. stands fifth among them. Structure Therapeutics Inc. (NASDAQ:GPCR) is a ...
Brazil’s Elea Data Centers has issued around US$150 million in sustainability-linked bonds, reinforcing its ESG commitments and supporting long-term AI infrastructure expansion. Elea Data Centers, ...
I maintain a 'hold' rating on Recursion Pharmaceuticals due to mixed early-stage clinical data for FAP and uncertain pipeline progression. REC-617 showed an encouraging partial response in ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is an emerging clinical-stage biotech firm that uses AI, bioinformatics, experimental biology, and automation to industrialize drug discovery for various ...
Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse events In comparison to placebo, treatment with REC-994 400 mg showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback